Switch to:
More From Other Websites
Is a Para IV Filing Rewarding for a Generic Company? Mar 25 2015
Regulations Are Instrumental in the Marketing Authorization Process Mar 25 2015
Why Is the Generics Industry Controlled by Regulations? Mar 25 2015
Bargaining Power Is in the Hands of the Distribution Industry Mar 25 2015
STOCKS FALL: Here's what you need to know Mar 24 2015
Citi thinks pharmaceutical giant Teva is set for a 'material, potentially transformative,... Mar 24 2015
Why Teva Pharmaceuticals Could Gain 25% Mar 24 2015
Teva Migraine Drug Scores In Race With Alder, Lilly Mar 23 2015
Generics Are Climbing up the Value Chain Mar 23 2015
What Two Factors Are Driving the US Generics Market? Mar 23 2015
4 Pharmaceutical Stocks to Buy for Outperformance in 2015 Mar 23 2015
Actavis' Wide-Moat Transformation Offers Shareholder Rewards Mar 23 2015
Gilead is Criticized for Restrictions on Generic Hepatitis C Drug Deal Mar 19 2015
Why the Generic Industry’s Classification Is Still Evolving Mar 19 2015
Are Generics the Only Affordable Drugs? Mar 19 2015
Teva Pharmaceuticals: Time for a Shopping Spree…and These Companies Could Be Targets Mar 17 2015
Sucampo Pharmaceuticals Revamp Impresses Wall Street Mar 17 2015
Mylan And Teva Are Catching The M&A Fever Mar 16 2015
Three trades to go before the closing bell Mar 16 2015
IBD 50 Stocks O'Reilly, Mylan Hover Near Buy Points Mar 13 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK